News

FogPharma, a biopharmaceutical company, has raised $107 million in Series C financing.

Edmonton, Alberta-based Future Fields, a biotechnology company focused on the cellular agriculture industry, has raised C$2.2 million in seed-stage financing.

GPs and LPs can see clearly now the rain is gone. The vaccine rollout is removing obstacles out of the way for face-to-face contact, and with the dark cloud of the pandemic slowly being lifted, the venture community is planning their return to the physical world for work, but they won’t entirely leave the virtual behind.

In venture capital and other investment categories, compensation trendlines take on new meaning amid covid-19, though little change is expected in 2021.

In the magazine: Why covid is leaving VCs with a hybrid business model; How the pandemic will affect your pay; LPs and GPs make progress on diversity; Plus much more…

Innovaccer Inc, a healthcare technology company, has closed its new funding round, bringing its total tally to over $225 million.

Torch, a San Francisco-based coaching platform, has raised over $25 million in Series B funding, according to a blog post.

Supplant, an Israeli agtech company, has raised $15 million in Series A funding, according to a spokesperson.

Tribeca Venture Partners is seeking to raise $150 million for its third fund, according to an SEC filing.

Bessemer Venture Partners has raised $3.3 billion across two new funds.